Park S M, Park J, Kim J G, Cho H D, Cho J H, Lee D H, Cha Y J
Dept. of Internal Medicine, College of Medicine, Chung-Ang University, Seoul, South Korea.
Scand J Gastroenterol. 1998 Sep;33(9):923-7. doi: 10.1080/003655298750026921.
Helicobacter pylori strains possessing the cagA gene have been postulated to have a disease-specific relationship to peptic ulcer. The purpose of this study was to investigate the relationship between the infection with Helicobacter pylori expressing the cagA gene and the development of peptic ulcer diseases in Korean patients.
Genomic DNA and bacterial mRNA in the gastric mucosa were amplified by polymerase chain reaction (PCR) and reverse transcription PCR, using synthetic oligonucleotide primers to cagA genes to compare the prevalence of cagA genes in 35 patients with non-ulcer gastritis and 99 patients with gastric or duodenal ulcer disease (53 and 46, respectively). Two different primer sets for the cagA gene were used. The first primer set amplified a 298-bp region (nucleotides 1751-2048), and the second set amplified a 349-bp region (nucleotides 1228-1249).
The expected 298 and 349-bp PCR amplicons were identified as follows: 1) 32 (91.4%) and 30 (85.7%) of 35 non-ulcer gastritis patients; 2) 5 1 (96.2%) and 50 (94.3%) of 53 benign gastric ulcer patients; and 3) 46 (100.0%) and 40 (87.0%) of 46 duodenal ulcer patients, respectively.
These results strongly suggest that the cagA gene will not prove to be a useful marker to distinguish disease-specific H. pylori strains in the development of peptic ulcer diseases in Korean patients.
据推测,携带cagA基因的幽门螺杆菌菌株与消化性溃疡存在疾病特异性关系。本研究旨在调查表达cagA基因的幽门螺杆菌感染与韩国患者消化性溃疡疾病发生之间的关系。
使用针对cagA基因的合成寡核苷酸引物,通过聚合酶链反应(PCR)和逆转录PCR扩增胃黏膜中的基因组DNA和细菌mRNA,以比较35例非溃疡性胃炎患者和99例胃溃疡或十二指肠溃疡疾病患者(分别为53例和46例)中cagA基因的流行情况。使用了两种不同的cagA基因引物组。第一组引物扩增出一个298 bp的区域(核苷酸1751 - 2048),第二组引物扩增出一个349 bp的区域(核苷酸1228 - 1249)。
预期的298和349 bp PCR扩增产物鉴定如下:1)35例非溃疡性胃炎患者中分别为32例(91.4%)和30例(85.7%);2)53例良性胃溃疡患者中分别为51例(96.2%)和50例(94.3%);3)46例十二指肠溃疡患者中分别为46例(100.0%)和40例(87.0%)。
这些结果有力地表明,在韩国患者消化性溃疡疾病的发生中,cagA基因不会被证明是区分疾病特异性幽门螺杆菌菌株的有用标志物。